Clinical trialNCT05941507RecruitingPhase 1/PHASE2Interventional

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

SponsorLigaChem Biosciences, Inc.Enrollment300Advanced Solid Tumors

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Rodrigo Ruiz-Soto, MD
AntibodyChem Biosciences
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Philippe Bedard, MD
Recruiting

United States

Cedars Sinai Medical Center
Los Angeles, California, United States
Yuan Yuan, MD
Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Glenn Hanna, MD
Recruiting
University of Michigan
Ann Arbor, Michigan, United States
Paul Swiecicki, MD
Recruiting
Tennessee Oncology
Nashville, Tennessee, United States
Jeff Russell, M.D.
Not, yet, recruiting
Mary Crowley Cancer Research
Dallas, Texas, United States
Douglas Orr, MD
Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Heather McArthur, M.D.
Not, yet, recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Funda Meric-Bernstam, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 Oct 2023
Primary completion: 31 Jan 2027
Completion: 31 May 2027
Last update posted: 24 Sept 2025
Registered enrollment: 300
Registry id: NCT05941507

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.